Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Neymark, N.
1998.
Critical reviews of economic analyses in order to make health care decisions for cancer.
Annals of Oncology,
Vol. 9,
Issue. 11,
p.
1167.
Van Enckevort, Petra J.
TenVergert, Elisabeth M.
Kingma, Johannes
Koëter, Gerard H.
and
Rutten, Frans F. H.
1999.
Factors to Consider When Designing Phase III Clinical Trials Involving Economic Evaluations.
Perceptual and Motor Skills,
Vol. 89,
Issue. 3_suppl,
p.
1059.
Dixon, Simon
Deverill, Mark
Gannon, Mary
Brazier, John
and
Haggard, Mark
1999.
Improving the Validity of Economic Evaluations Alongside Controlled Trials.
Journal of Health Services Research & Policy,
Vol. 4,
Issue. 3,
p.
161.
Velikova, G
Stark, D
and
Selby, P
1999.
Quality of life instruments in oncology.
European Journal of Cancer,
Vol. 35,
Issue. 11,
p.
1571.
Lehoux, Pascale
and
Blume, Stuart
2000.
Technology Assessment and the Sociopolitics of Health Technologies.
Journal of Health Politics, Policy and Law,
Vol. 25,
Issue. 6,
p.
1083.
Lyman, Gary H.
2001.
Economic analysis of randomized, controlled trials.
Current Oncology Reports,
Vol. 3,
Issue. 5,
p.
396.
Ramsey, S. D.
Moinpour, C. M.
Lovato, L. C.
Crowley, J. J.
Grevstad, P.
Presant, C. A.
Rivkin, S. E.
Kelly, K.
and
Gandara, D. R.
2002.
Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer.
JNCI Journal of the National Cancer Institute,
Vol. 94,
Issue. 4,
p.
291.
Brown, Martin L.
Knopf, Kevin B.
Marcus, Stephen E.
and
Lipscomb, Joseph
2002.
Principles and Practice of Clinical Research.
p.
275.
Coyle, D.
Barbeau, M.
Guttman, M.
and
Baladi, J.-F.
2003.
The economic evaluation of pharmacotherapies for Parkinson's disease.
Parkinsonism & Related Disorders,
Vol. 9,
Issue. 5,
p.
301.
Johnston, Katharine
2003.
Evidence‐based Oncology.
p.
25.
Soto Álvarez, Javier
2003.
Inclusión de análisis farmacoeconómicos en ensayos clínicos: principios y prácticas.
Medicina Clínica,
Vol. 120,
Issue. 6,
p.
227.
Cook, John
Drummond, Michael
and
Heyse, Joseph F
2004.
Economic endpoints in clinical trials.
Statistical Methods in Medical Research,
Vol. 13,
Issue. 2,
p.
157.
Lyman, Gary H.
and
Kuderer, Nicole M.
2004.
Hematopoietic Growth Factors in Oncology.
p.
409.
Korthals-de Bos, Ingeborg
van Tulder, Maurits
van Dieten, Hiske
and
Bouter, Lex
2004.
Economic Evaluations and Randomized Trials in Spinal Disorders: Principles and Methods.
Spine,
Vol. 29,
Issue. 4,
p.
442.
Lyman, G.H.
and
Kuderer, N.M.
2004.
The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropenia.
Critical Reviews in Oncology/Hematology,
Vol. 50,
Issue. 2,
p.
129.
Korthals-de Bos, Ingeborg B C
Smidt, Nynke
van Tulder, Maurits W
Rutten-van M??lken, Maureen P M H
Ad??r, Herman J
van der Windt, Dani??lle A W M
Assendelft, Willem J J
and
Bouter, Lex M
2004.
Cost Effectiveness of Interventions for Lateral Epicondylitis.
PharmacoEconomics,
Vol. 22,
Issue. 3,
p.
185.
Negrini, C.
Wahlqvist, P.
Rossi, C.
Dubini, A.
and
Savarino, V.
2005.
Valutazione economica della terapia di mantenimento al bisogno con esomeprazolo nella malattia da reflusso gastroesofageo.
PharmacoEconomics Italian Research Articles,
Vol. 7,
Issue. 1,
p.
67.
Hansen, A. N.
Wahlqvist, P.
Jørgensen, E.
Bergheim, R.
Fagertun, H.
Lund, H.
and
Moum, B.
2005.
Six-month management of patients following treatment for gastroesophageal reflux disease symptoms - a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical pr.
International Journal of Clinical Practice,
Vol. 59,
Issue. 6,
p.
655.
O'Sullivan, Amy K.
Thompson, David
and
Drummond, Michael F.
2005.
Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations?.
Value in Health,
Vol. 8,
Issue. 1,
p.
67.
Lave, Judith R.
and
Frank, Richard G.
2005.
Encyclopedia of Biostatistics.